本港新增7宗新型冠状病毒病确诊个案 累计148宗
卫生署卫生防护中心公布,截至昨日(3月15日)晚上八时,中心正调查7宗新增2019冠状病毒病确诊个案,至今本港个案累计149宗(包括148宗确诊个案和1宗疑似个案)。昨日所有新增个案的病人於潜伏期均有外游。
第1宗个案涉及一名35岁男子(为第143宗个案),他过往健康良好,居於粉岭华明村礼明楼。病人於2月26至3月11日曾到日本北海道,3月7日曾陪同朋友到访北海道二世古一所诊所。他於3月11日由北海道乘坐日本航空JL2504(经济舱)到大阪,再由大阪乘坐国泰航空CX561(经济舱)於同日晚上抵港。
第2宗个案涉及一名29岁男子(为第144宗个案),他过往健康良好。病人於3月5日由香港前往德国,3月7日转往奥地利,3月11日返回德国,并於3月12日由慕尼黑乘坐汉莎航空LH119(经济舱)到法兰克福,再由法兰克福乘坐LH796(商务舱)於3月13日抵港,抵港後一直独自於湾仔湾景国际酒店居住。
第3宗与第4宗个案分别涉及一名37岁男子(为第145宗个案)及一名39岁男子(为第146宗个案)。中心的流行病学调查显示,他们於潜伏期内曾一同前往法国,并由巴黎乘坐国泰航空CX260(经济舱)於3月13日抵港。
第5宗及第6宗个案涉及一对夫妇,分别为61岁女子(为第147宗个案)及58岁男子(为第148宗个案),两人有长期病患,居於加列山道65号嘉丽园。他们於2月15日至3月2日到访多伦多,3月2日至5日到访纽约,3月5日至9日到访波士顿,并在波士顿乘坐国泰航空CX811(商务舱)於3月10日抵港。
第7宗个案涉及一名32岁男子(为第149宗个案),他过往健康良好,居於薄扶林华富(二)村华昌楼。病人於2月24日至3月2日参加旅行团从香港到突尼西亚旅游,其後於3月3至9日与朋友到访英国及西班牙,并於3月10日回到香港。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.